Wake Network Retains CRO Santé Cannabis to Conduct Clinical Trials in Psilocybin Therapies
Ryan Allway June 16th, 2021 Psychedelics TORONTO, June 16, 2021 /CNW/ – Wake Network Inc. (“Wake” or the “Company“), a global leader in psilocybin and medicinal mushroom production and developer of genomics-based integration therapies, is pleased to announce that it has entered into an agreement with Santé Cannabis (“Sante”) for consultation and... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )